Profund Advisors LLC Rapt Therapeutics, Inc. Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$11.28 - $25.46 $17,675 - $39,895
-1,567 Reduced 9.36%
15,167 $376,000
Q3 2023

Nov 13, 2023
SELL
$16.34 - $24.66 $105,343 - $158,983
-6,447 Reduced 27.81%
16,734 $278,000
Q2 2023

Aug 10, 2023
BUY
$16.06 - $21.61 $37,869 - $50,956
2,358 Added 11.32%
23,181 $433,000
Q1 2023

May 11, 2023
BUY
$17.19 - $30.8 $357,947 - $641,348
20,823 New
20,823 $382,000

Others Institutions Holding RAPT

# of Institutions
105
Shares Held
27.1M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $35.6M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email